According to ChemoMetec's latest financial reports and stock price the company's current Operating Margin is 47.79%. At the end of 2022 the company had an Operating Margin of 47.79%.
Year | Operating Margin | Change |
---|---|---|
2022 | 47.79% | 18.22% |
2021 | 40.43% | 12.25% |
2020 | 36.02% | 16.14% |
2019 | 31.01% | 44.46% |
2018 | 21.47% | 99.5% |
2017 | 10.76% | -38.77% |
2016 | 17.57% | 51.43% |
2015 | 11.60% | 312.6% |
2014 | 2.81% | -5.35% |
2013 | 2.97% | -110.13% |
2012 | -29.32% | -1512.21% |
2011 | 2.08% | -153.73% |
2010 | -3.86% | -160.12% |
2009 | 6.43% | -80.49% |
2008 | 32.94% | 413.56% |
2007 | 6.41% | 24.4% |
2006 | 5.16% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.